InventisBio Co., Limited (SHA:688382)

InventisBio Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,382	1,586	1,919	2,235	724.25	1,032
Short-Term Investments	-	-	-	-	-	1.32
Trading Asset Securities	153.01	101.3	-	-	-	-
Cash & Short-Term Investments	1,535	1,687	1,919	2,235	724.25	1,033
Cash Growth	-5.48%	-12.10%	-14.13%	208.62%	-29.90%	2668.59%
Accounts Receivable	163.13	165.34	176.57	-	-	-
Other Receivables	4.21	5.93	6.65	3.98	4.25	-
Receivables	167.34	171.28	183.21	3.98	4.25	-
Other Current Assets	12.43	11.69	20.46	26.28	12.95	5.5
Total Current Assets	1,714	1,870	2,123	2,265	741.45	1,039
Property, Plant & Equipment	30.41	44.82	30.38	47.14	44.02	8.96
Other Intangible Assets	1.73	0.59	0.92	1.25	0.11	-
Long-Term Deferred Tax Assets	3.07	3.44	2.9	6.22	-	-
Long-Term Deferred Charges	10.55	-	1.05	4.4	8.42	3.23
Other Long-Term Assets	4.21	1.86	3.9	23.35	6.02	6.05
Total Assets	1,764	1,921	2,162	2,348	800.03	1,057
Accounts Payable	56.61	59.96	72.52	62.25	64.22	30.57
Accrued Expenses	15.13	21.62	28.86	36.19	25.71	13.68
Current Portion of Leases	6.6	7.79	9	12.07	8.71	-
Current Unearned Revenue	-	-	47.17	-	-	-
Other Current Liabilities	2.15	0.61	0.72	0.51	0.22	1.64
Total Current Liabilities	80.56	89.98	158.27	111.02	98.85	45.89
Long-Term Leases	14.79	16.13	2.61	15.27	14.94	-
Long-Term Unearned Revenue	0.48	0.48	0.88	0.4	1.2	0.8
Long-Term Deferred Tax Liabilities	3.21	3.44	2.9	6.22	-	-
Total Liabilities	99.04	110.03	164.67	132.9	115	46.69
Common Stock	578.35	576.75	575	575	460	460
Additional Paid-In Capital	3,826	3,791	3,738	3,671	1,773	1,740
Retained Earnings	-2,726	-2,545	-2,305	-2,021	-1,537	-1,179
Comprehensive Income & Other	-12.46	-11.9	-10.74	-10.4	-10.79	-10.05
Shareholders' Equity	1,665	1,811	1,998	2,215	685.03	1,010
Total Liabilities & Equity	1,764	1,921	2,162	2,348	800.03	1,057
Total Debt	21.39	23.92	11.62	27.34	23.66	-
Net Cash (Debt)	1,513	1,663	1,908	2,208	700.6	1,033
Net Cash Growth	-5.38%	-12.82%	-13.59%	215.14%	-32.20%	2668.59%
Net Cash Per Share	2.59	2.89	3.32	4.34	1.53	2.25
Filing Date Shares Outstanding	578.35	576.75	575	575	460	460
Total Common Shares Outstanding	578.35	576.75	575	575	460	460
Working Capital	1,634	1,780	1,965	2,154	642.6	992.85
Book Value Per Share	2.88	3.14	3.47	3.85	1.49	2.20
Tangible Book Value	1,664	1,810	1,997	2,214	684.92	1,010
Tangible Book Value Per Share	2.88	3.14	3.47	3.85	1.49	2.20
Machinery	-	32.55	32.04	27.07	23.91	6.51
Construction In Progress	-	6.47	0.5	2.58	1.87	3.88

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.